IBM
54
4
K
62
6
EMR
51
3
NWL
35
3
FE
70
4
EQT
56
2
NOC
47
2
CL
50
2
HPE
50
-2
AMG
55
5
MCD
47
-2
MCK
80
3
NWSA
76
3
HUM
31
-3
AMT
52
9
MHK
55
5
AZO
62
4
PLD
35
3
KHC
42
2
NEM
61
-2
IBM
54
4
K
62
6
EMR
51
3
NWL
35
3
FE
70
4
EQT
56
2
NOC
47
2
CL
50
2
HPE
50
-2
AMG
55
5
MCD
47
-2
MCK
80
3
NWSA
76
3
HUM
31
-3
AMT
52
9
MHK
55
5
AZO
62
4
PLD
35
3
KHC
42
2
NEM
61
-2
Financhill
Back

Ekso Bionics Holdings 10K Form

Sell
34

EKSO
Ekso Bionics Holdings

Last Price:
$0.49
Seasonality Move:
-13.94%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive EKSO News And Ratings

See the #1 stock for the next 7 days that we like better than EKSO

EKSO Financial Statistics

Sales & Book Value

Annual Sales: $17.9M
Cash Flow: $-1.5M
Price / Cash Flow: 0
Annual Sales: $0.57
Price / Book: 0.96

Profitability

EPS (TTM): -0.57000
Net Income (TTM): $-11.3M
Gross Margin: $9.5M
Return on Equity: -85.45%
Return on Assets: -40.26%

Ekso Bionics Holdings Earnings Forecast

Key Ekso Bionics Holdings Financial Ratios

  • The Gross Profit Margin over the past 11 years for EKSO is 53.06%.
  • The Selling, General & Administrative Expenses for EKSO have been equal to 89.80% of Gross Profit Margin.
  • The Research & Development expenses have been 21.61% of Revenue.
  • The Net Earning history of EKSO is -63.21% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 8 years.

Ekso Bionics Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: EKSO
CUSIP: 282644
Website: eksobionics.com

Debt

Debt-to-Equity Ratio: 0.4
Current Ratio: 2.5
Quick Ratio: 1.82

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

EKSO Technical Analysis vs Fundamental Analysis

Sell
34
Ekso Bionics Holdings (EKSO) is a Sell

Is Ekso Bionics Holdings a Buy or a Sell?